A multi-objective production planning problem with the consideration of time and cost in clinical trials
Under increasingly challenging circumstances, pharmaceutical companies try to reduce the overproduction of clinical drugs, which is commonly seen in the pharmaceutical industry. When the overproduction is simply reduced without an efficient coordination of the inventories in the supply chain, the st...
Saved in:
Main Authors: | Zhao, Hui, Huang, Edward, Dou, Runliang, Wu, Kan |
---|---|
Other Authors: | School of Mechanical and Aerospace Engineering |
Format: | Article |
Language: | English |
Published: |
2021
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/152090 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Do firms respond to peer disclosures? Evidence from clinical trial disclosures
by: CAPKUN, Vedran, et al.
Published: (2021) -
Do firms respond to peer disclosures? Evidence from disclosures of clinical trial results
by: CAPKUN, Vedran, et al.
Published: (2023) -
Adaptive design methods in clinical trials - A review
by: Chow, S.-C, et al.
Published: (2020) -
Multi-objective analysis of the supply chain
by: Krishnamoorthy Harihara Seshadri.
Published: (2008) -
Non-bleeding side effects of clopidogrel: Have large multi-center clinical trials underestimated their incidence?
by: Almsherqi, Z.A., et al.
Published: (2011)